thirty-two patients with a diagnosis of primary inflammatory breast carcinoma were treated with combination chemoimmunotherapy consisting of 5-fluorouracil , doxorubicin hydrochloride ( adriamycin ) , and cyclophosphamide ( fac ) plus bcg followed by radiation therapy .
C0546861
doxorubicin hydrochloride
C0085752
adriamycin